Springer Nature is making SARS-CoV-2 and COVID-19 research free.
View research |
View latest news |
Sign up for updates
From: Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR